Kindred’s Expansion: Bringing Retail to Washington State – A Milestone for North America

Kindred Group Expands Partnership with The Swinomish Tribe Bringing Entertainment and Opportunities to Washington State It’s always exciting to hear about companies expanding their reach and partnering with communities to bring new opportunities and entertainment options to the public. Kindred Group plc (Kindred) recently announced the launch of a retail operation at the Swinomish Casino…

Read More

Get Ready to Experience Macao Like Never Before: Galaxy Macau Takes on Lisbon’s Unlimited Macao Exhibition!

Galaxy Macau Shines Bright at Macao Exhibition in Lisbon Step into Luxury at Galaxy Macau Galaxy Macau, the epitome of luxury and opulence, is making waves at the “Experience Macao Unlimited – Macao Exhibition in Lisbon.” This world-class integrated resort is pulling out all the stops to showcase its unparalleled grandeur and sophistication to Europe…

Read More

Unleashing the Power of Zero-Party Data: Marigold Experiences for Enterprise Now Available to Selligent Customers!

New Marigold Solution Makes it Easy for Selligent Customers to Collect and Activate Zero-Party Data and Preference Insights through Real-Time Interactive Experiences BRUSSELS, Belgium and NASHVILLE, Tenn., April 20, 2023 (GLOBE NEWSWIRE) — Marigold, a global martech leader focused on delivering relationship marketing solutions that help marketers acquire, grow and retain customers, today launched Marigold…

Read More

Unlocking the Secrets of FX Option Expiries: A Guide to the 10am New York Cut on April 20th

The Impact of Options Expiry Levels on Forex Markets EUR/USD EUR/USD options expiry levels are crucial to watch as they can have a significant impact on the currency pair’s movements. The levels for EUR/USD are currently at 1.0870-85 (€1.6bn), 1.0895-00 (€1.1bn), 1.0920-25 (€1.9bn), 1.0975-80 (€948m), 1.1000-10 (€1.3bn), and 1.1100 (€1.1bn). Of particular interest are the…

Read More

Breaking News: Innocare’s Orelabrutinib Makes History as China’s First and Only Approved BTK Inhibitor for Treating R/R MZL

Exciting News in the Biopharmaceutical Industry Beijing–InnoCare Pharma (HKEX: 09969; SSE: 688428) has made a groundbreaking announcement today, revealing that its BTK inhibitor orelabrutinib has been granted approval by the China National Medical Products Administration (NMPA) for the treatment of patients with relapsed/refractory (r/r) marginal zone lymphoma (MZL). This marks a significant milestone as orelabrutinib…

Read More